Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry.
Ernest K. Amankwah(Johns Hopkins University), Catherine Phelan(Moffitt Cancer Center), Ellen L. Goode(Mayo Clinic in Arizona), Thomas A. Sellers(Mayo Clinic), Hui‐Yi Lin(Moffitt Cancer Center), Andrew Berchuck(General Marble (Greece)), Simon A. Gayther(The University of Texas Health Science Center at Houston), Ya-Yu Tsai(Moffitt Cancer Center), Susan J. Ramus(Cancer Institute of New South Wales), Edward Iverson(Duke University), Joellen M. Schildkraut(Duke University Hospital), Álvaro N.A. Monteiro(Moffitt Cancer Center), Gang Han(Texas A&M Health Science Center), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Steven A. Narod(Women's College Hospital), Zhihua Chen(Shanghai University), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Julie Cunninghan(Mayo Clinic in Arizona), Jonathan P. Tyrer(University of Cambridge)
Cited by 0
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k